1029 COST-EFFECTIVENESS ANALYSIS OF THE EASL 2009 CLINICAL PRACTICE GUIDELINES FOR MANAGEMENT OF CHRONIC HEPATITIS B IN FRANCE, ITALY, PORTUGAL, SPAIN, TURKEY AND THE UNITED KINGDOM

2010 ◽  
Vol 52 ◽  
pp. S398
Author(s):  
D.J. Vanness ◽  
C. Singfield ◽  
I.A. Joseph ◽  
F. van Nooten ◽  
K. Agarwal ◽  
...  
Keyword(s):  
Chronic Hepatitis ◽  
United Kingdom ◽  
Clinical Practice ◽  
Cost Effectiveness ◽  
Hepatitis B ◽  
Chronic Hepatitis B ◽  
Clinical Practice Guidelines ◽  
Practice Guidelines ◽  
The United Kingdom ◽  
Effectiveness Analysis

scholarly journals Management of chronic hepatitis B in childhood: ESPGHAN clinical practice guidelines

2013 ◽  
Vol 59 (4) ◽  
pp. 814-829 ◽  
Author(s):  
Etienne M. Sokal ◽  
Massimiliano Paganelli ◽  
Stefan Wirth ◽  
Piotr Socha ◽  
Pietro Vajro ◽  
...  
Keyword(s):  
Chronic Hepatitis ◽  
Clinical Practice ◽  
Hepatitis B ◽  
Chronic Hepatitis B ◽  
Clinical Practice Guidelines ◽  
Practice Guidelines

scholarly journals Comparison of clinical practice guidelines for the management of chronic hepatitis B: When to start, when to change, and when to stop

2020 ◽  
Vol 26 (4) ◽  
pp. 411-429
Author(s):  
Hyung Joon Yim ◽  
Ji Hoon Kim ◽  
Jun Yong Park ◽  
Eileen L. Yoon ◽  
Hana Park ◽  
...  
Keyword(s):  
Chronic Hepatitis ◽  
Clinical Practice ◽  
Hepatitis B ◽  
Chronic Hepatitis B ◽  
Clinical Practice Guidelines ◽  
Practice Guidelines ◽  
Antiviral Agents ◽  
The United States ◽  
Medical Practitioners ◽  
Asian Pacific

Clinical practice guidelines are important for guiding the management of specific diseases by medical practitioners, trainees, and nurses. In some cases, the guidelines are utilized as a reference for health policymakers in controlling diseases with a large public impact. With this in mind, practice guidelines for the management of chronic hepatitis B (CHB) have been developed in the United States, Europe, and Asian-Pacific regions to suggest the best-fit recommendations for each social and medical circumstance. Recently, the Korean Association for the Study of the Liver published a revised version of its clinical practice guidelines for the management of CHB. The guidelines included updated information based on newly available antiviral agents, the most recent opinion on the initiation and cessation of treatment, and updates for the management of drug resistance, partial virological response, and side effects. Additionally, CHB management in specific situations was comprehensively revised. This review compares the similarities and differences among the various practice guidelines to identify unmet needs and improve future recommendations.

Sign in / Sign up

Export Citation Format

Share Document